prednisolone has been researched along with Cardiovascular Diseases in 36 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the long-term effects of early low-dose prednisolone use in patients with rheumatoid arthritis (RA) on cardiovascular (CV) morbidity and mortality." | 9.19 | Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial. ( Ajeganova, S; Hafström, I; Svensson, B, 2014) |
| "To examine the long-term effects of early low-dose prednisolone use in patients with rheumatoid arthritis (RA) on cardiovascular (CV) morbidity and mortality." | 5.19 | Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial. ( Ajeganova, S; Hafström, I; Svensson, B, 2014) |
| " We sought to test the hypothesis that tapering of prednisolone (TAP) the first year after renal transplantation improves insulin sensitivity (IS), and to assess the effect of complete steroid withdrawal (SW) on IS in patients on a cyclosporine-based immunosuppressive regimen." | 5.11 | Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. ( Egeland, T; Hartmann, A; Hjelmesaeth, J; Jenssen, T; Lund, K; Midtvedt, K; Paulsen, D, 2004) |
| " History of lupus nephritis and a higher average dose of prednisolone used since diagnosis were associated with cIMT progression in patients." | 3.96 | Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisol ( Ajeganova, S; Frostegård, J; Gustafsson, T; Hafström, I; Lindberg, L, 2020) |
| "Our results indicate that obesity, distribution of obesity, and prednisolone treatment are the predominant determinants of insulin resistance long term after transplantation." | 3.74 | Determinants of insulin resistance in renal transplant recipients. ( Bakker, SJ; de Jong, PE; de Vries, AP; Gans, RO; Gansevoort, RT; Oterdoom, LH; Ploeg, RJ; van der Heide, JJ; van Son, WJ, 2007) |
| "Hypercholesterolemia was observed in 46% to 80% and hypertriglyceridemia in 43% to 78% of sirolimus-treated patients during the first 6 posttransplantation months." | 3.72 | Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis. ( Chueh, SC; Kahan, BD, 2003) |
| "Treatment with leflunomide or low doses of glucocorticoids were not associated with severe course in our cohort." | 2.82 | COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia. ( Hočevar, A; Ješe, R; Kramarič, J; Rotar, Ž; Tomšič, M, 2022) |
| " Hence, a reduction in CsA dosage in kidney transplant recipients (KTR) may improve long-term outcomes." | 2.71 | Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction. ( Cardarelli, F; Cosimi, AB; Delmonico, FL; Farrell, ML; Pascual, M; Saidman, SL; Shih, V; Tolkoff-Rubin, N; Winkelmayer, WC; Wong, W, 2004) |
| "Cancer was less common in recipients with a higher BMI (hazard ratio (HR) 0." | 1.48 | Is big bad or bearable? Long-term renal transplant outcomes in obese recipients. ( Courtney, AE; Devine, PA; McCaughan, JA; McCloskey, OM, 2018) |
| "Hypercholesterolemia was evident in 66." | 1.30 | Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation. ( Bechstein, WO; Guckelberger, O; Jonas, S; Kratschmer, B; Lemmens, HP; Luesebrink, R; Neuhaus, PL; Neuhaus, R, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (27.78) | 18.7374 |
| 1990's | 4 (11.11) | 18.2507 |
| 2000's | 10 (27.78) | 29.6817 |
| 2010's | 8 (22.22) | 24.3611 |
| 2020's | 4 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Kramarič, J | 1 |
| Ješe, R | 1 |
| Tomšič, M | 1 |
| Rotar, Ž | 1 |
| Hočevar, A | 1 |
| Ajeganova, S | 2 |
| Gustafsson, T | 1 |
| Lindberg, L | 1 |
| Hafström, I | 2 |
| Frostegård, J | 1 |
| Vedder, D | 1 |
| Nurmohamed, MT | 1 |
| McCloskey, OM | 1 |
| Devine, PA | 1 |
| Courtney, AE | 1 |
| McCaughan, JA | 1 |
| Rahvar, AH | 1 |
| Haas, CS | 1 |
| Danneberg, S | 1 |
| Harbeck, B | 1 |
| van Dijk, M | 1 |
| van Roon, AM | 1 |
| Said, MY | 1 |
| Bemelman, FJ | 1 |
| Homan van der Heide, JJ | 1 |
| de Fijter, HW | 1 |
| de Vries, APJ | 1 |
| Bakker, SJL | 1 |
| Sanders, JSF | 1 |
| Nielsen, CB | 1 |
| Nielsen, C | 1 |
| Nybo, M | 1 |
| Just, SA | 1 |
| Vinholt, PJ | 1 |
| Svensson, B | 1 |
| Barzenje, DA | 1 |
| Cvancarova Småstuen, M | 1 |
| Liestøl, K | 1 |
| Fosså, A | 1 |
| Delabie, J | 1 |
| Kolstad, A | 1 |
| Holte, H | 1 |
| Verhoeven, F | 1 |
| Totoson, P | 1 |
| Maguin-Gaté, K | 1 |
| Prigent-Tessier, A | 1 |
| Marie, C | 1 |
| Wendling, D | 1 |
| Moretto, J | 1 |
| Prati, C | 1 |
| Demougeot, C | 1 |
| Sugiyama, T | 1 |
| Suzuki, S | 1 |
| Yoshida, T | 1 |
| Suyama, K | 1 |
| Tanaka, T | 1 |
| Sueishi, M | 1 |
| Tatsuno, I | 1 |
| Takagi, S | 1 |
| Komatsu, N | 1 |
| Martínez-Berriotxoa, A | 1 |
| Ruiz-Irastorza, G | 1 |
| Egurbide Arberas, MV | 1 |
| Rueda Gutiérrez, M | 1 |
| Aguirre Errasti, C | 1 |
| Chueh, SC | 1 |
| Kahan, BD | 1 |
| BRIGDEN, W | 1 |
| SIEGENTHALER, W | 1 |
| SIEGENTHALER, G | 1 |
| BONER, A | 1 |
| DOUGLAS, AC | 1 |
| Lyman, GH | 1 |
| Morrison, VA | 1 |
| Dale, DC | 1 |
| Crawford, J | 1 |
| Delgado, DJ | 1 |
| Fridman, M | 1 |
| Wong, W | 1 |
| Tolkoff-Rubin, N | 1 |
| Delmonico, FL | 1 |
| Cardarelli, F | 1 |
| Saidman, SL | 1 |
| Farrell, ML | 1 |
| Shih, V | 1 |
| Winkelmayer, WC | 1 |
| Cosimi, AB | 1 |
| Pascual, M | 1 |
| Midtvedt, K | 1 |
| Hjelmesaeth, J | 1 |
| Hartmann, A | 1 |
| Lund, K | 1 |
| Paulsen, D | 1 |
| Egeland, T | 1 |
| Jenssen, T | 1 |
| Raza, K | 1 |
| Banks, M | 1 |
| Kitas, GD | 1 |
| Oterdoom, LH | 1 |
| de Vries, AP | 1 |
| Gansevoort, RT | 1 |
| van Son, WJ | 1 |
| van der Heide, JJ | 1 |
| Ploeg, RJ | 1 |
| de Jong, PE | 1 |
| Gans, RO | 1 |
| Bakker, SJ | 1 |
| Sonneveld, P | 1 |
| de Ridder, M | 1 |
| van der Lelie, H | 1 |
| Nieuwenhuis, K | 1 |
| Schouten, H | 1 |
| Mulder, A | 1 |
| van Reijswoud, I | 1 |
| Hop, W | 1 |
| Lowenberg, B | 1 |
| Koike, M | 1 |
| Ishiyama, T | 1 |
| Guckelberger, O | 1 |
| Bechstein, WO | 1 |
| Neuhaus, R | 1 |
| Luesebrink, R | 1 |
| Lemmens, HP | 1 |
| Kratschmer, B | 1 |
| Jonas, S | 1 |
| Neuhaus, PL | 1 |
| Yoshida, C | 1 |
| Miyachi, Y | 1 |
| Hall, RL | 1 |
| Leahy, MF | 1 |
| Uddhammar, A | 1 |
| Eriksson, AL | 1 |
| Nyström, L | 1 |
| Stenling, R | 1 |
| Rantapää-Dahlqvist, S | 1 |
| Moroni, G | 1 |
| Banfi, G | 1 |
| Ponticelli, C | 1 |
| Morandini, G | 1 |
| Spanedda, M | 1 |
| Spanedda, L | 1 |
| Egorova, LI | 1 |
| Moiseev, VS | 2 |
| Fiegel, G | 1 |
| Gardell, C | 1 |
| Tuchweber, B | 1 |
| Hatakeyama, S | 1 |
| Kovacs, K | 1 |
| Argov, IuM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System.[NCT03367663] | Early Phase 1 | 10 participants (Actual) | Interventional | 2018-01-17 | Completed | ||
| TransplantLines Insulin Resistance and Inflammation Biobank and Cohort Study[NCT03272854] | 606 participants (Actual) | Observational [Patient Registry] | 2001-08-31 | Active, not recruiting | |||
| ACtive Care After Transplantation, a Lifestyle Intervention in Renal Transplant Recipients[NCT01047410] | 221 participants (Actual) | Interventional | 2010-10-31 | Completed | |||
| Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA, Versus Standard Dose Tacrolimus, ECMPA Plus Corticosteroids in Patients Undergoing Liver Transplant[NCT02123108] | Phase 4 | 59 participants (Actual) | Interventional | 2011-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT02123108)
Timeframe: 12 months post liver transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 3 |
| Tacrolimus Group | 4 |
(NCT02123108)
Timeframe: 12 months post liver transplantation
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 0 |
| Tacrolimus Group | 0 |
(NCT02123108)
Timeframe: 12 months post transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 2 |
| Tacrolimus Group | 5 |
Number of participants who experienced dialysis independence or improvement based upon kidney function labs as a measure of renal recovery/ function following OLT in patients after undergoing orthotopic liver transplant (NCT02123108)
Timeframe: 12 months post-transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 28 |
| Tacrolimus Group | 26 |
Participants at risk minus incidence of death within the first year post-transplant (NCT02123108)
Timeframe: 12 months post liver transplant
| Intervention | Participants (Count of Participants) |
|---|---|
| Basiliximab | 28 |
| Tacrolimus Group | 26 |
9 reviews available for prednisolone and Cardiovascular Diseases
| Article | Year |
|---|---|
COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia.
Topics: Cardiovascular Diseases; COVID-19; Giant Cell Arteritis; Glucocorticoids; Humans; Hypertension; Lefl | 2022 |
Increased Cardiovascular Risk in Patients with Adrenal Insufficiency: A Short Review.
Topics: Adrenal Insufficiency; Cardiovascular Diseases; Cardiovascular System; Glucocorticoids; Hormone Repl | 2017 |
Risk-benefit assessment in management of adult idiopathic thrombocytopenic purpura.
Topics: Adrenal Cortex Hormones; Animals; Arteriosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Huma | 2011 |
[TREATMENT OF KIDNEY DISEASES, CARDIAC AND VASCULAR DISORDERS AS WELL AS COLLAGENOSES WITH CORTISONES].
Topics: Adams-Stokes Syndrome; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis, Rheumatoid; | 1964 |
[Hypereosinophilic syndrome].
Topics: Adult; Aged; Cardiovascular Diseases; Eosinophilia; Female; Humans; Hydroxyurea; Leukemia, Eosinophi | 1993 |
[Lipid metabolism in Cushing's syndrome].
Topics: Cardiovascular Diseases; Cushing Syndrome; Humans; Hyperlipidemias; Insulin Resistance; Lipid Metabo | 2001 |
[Use of cortisol and its derivatives in clinic practice].
Topics: Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenocorticotropic Hormone; Arthritis, Rheumatoid; | 1967 |
[Use of glucocorticoid hormones in the pathology of the cardiovascular system].
Topics: Adrenal Glands; Animals; Cardiovascular Diseases; Cell Membrane; Cortisone; Diuresis; Electrocardiog | 1972 |
[Pathologic changes in the cardiovascular system during treatment with glucocorticoid hormones].
Topics: Animals; Arteriosclerosis; Arthritis, Rheumatoid; Asparagine; Biological Transport, Active; Calcium; | 1972 |
5 trials available for prednisolone and Cardiovascular Diseases
| Article | Year |
|---|---|
Long-term cardiovascular outcome of renal transplant recipients after early conversion to everolimus compared to calcineurin inhibition: results from the randomized controlled MECANO trial.
Topics: Adult; Basiliximab; Calcineurin; Calcineurin Inhibitors; Cardiovascular Diseases; Carotid Intima-Med | 2018 |
Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial.
Topics: Age Factors; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Coronary Dise | 2014 |
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.
Topics: Adult; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cyclosporine; Female; Graft Surv | 2004 |
Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal.
Topics: Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucocorticoids; Graft Rejection; H | 2004 |
Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined | 1995 |
22 other studies available for prednisolone and Cardiovascular Diseases
| Article | Year |
|---|---|
Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisol
Topics: Adult; Aged; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case- | 2020 |
[Increased cardiovascular risk due to glucocorticoids: how strong is the evidence?]
Topics: Adrenal Cortex Hormones; Arrhythmias, Cardiac; Cardiovascular Diseases; Dose-Response Relationship, | 2021 |
Is big bad or bearable? Long-term renal transplant outcomes in obese recipients.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus; Female; Graft Rejec | 2018 |
The in vitro effect of antirheumatic drugs on platelet function.
Topics: Adalimumab; Adenosine Diphosphate; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Blood Pl | 2020 |
Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiova | 2015 |
Glucocorticoids improve endothelial function in rheumatoid arthritis: a study in rats with adjuvant-induced arthritis.
Topics: Acetylcholine; Animals; Aorta; Arginase; Arthritis; Arthritis, Experimental; Arthritis, Rheumatoid; | 2017 |
Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Cardiovascular Diseases; Cohort Studies; Confi | 2010 |
[Plasma homocysteine levels in systemic lupus erythematosus].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Cardiovascular Diseases; Cholesterol; Creatinine; | 2003 |
Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis.
Topics: Adult; Anti-Inflammatory Agents; Cardiovascular Diseases; Cohort Studies; Cyclosporine; Disease Prog | 2003 |
Cardiovascular disease: heart and major vessels; medical.
Topics: Cardiovascular Diseases; Heart; Humans; Prednisolone | 1958 |
SARCOIDOSIS.
Topics: Adrenal Cortex Hormones; Bone Diseases; Cardiovascular Diseases; Dermatology; Endocrinology; Eye Man | 1964 |
Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Te | 2003 |
Reversing myocardial microvascular disease in a patient with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cardiovascular Diseases; Coronary Angiography; Coronary Circulation; Cyclospo | 2005 |
Determinants of insulin resistance in renal transplant recipients.
Topics: Adult; Aged; Body Composition; Body Mass Index; Cardiovascular Diseases; Exercise; Female; Follow-Up | 2007 |
Determinants of insulin resistance in renal transplant recipients.
Topics: Adult; Aged; Body Composition; Body Mass Index; Cardiovascular Diseases; Exercise; Female; Follow-Up | 2007 |
Determinants of insulin resistance in renal transplant recipients.
Topics: Adult; Aged; Body Composition; Body Mass Index; Cardiovascular Diseases; Exercise; Female; Follow-Up | 2007 |
Determinants of insulin resistance in renal transplant recipients.
Topics: Adult; Aged; Body Composition; Body Mass Index; Cardiovascular Diseases; Exercise; Female; Follow-Up | 2007 |
Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation.
Topics: Adolescent; Adult; Aged; Blood Glucose; Cardiovascular Diseases; Cyclosporine; Female; Follow-Up Stu | 1997 |
Acquired Factor VIII autoantibody: four cases demonstrating the heterogenous nature of this condition and problems involved in diagnosis and treatment.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Azathiop | 2001 |
Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Comorbidity; Dose-Response Relatio | 2002 |
Clinical status of patients after 10 years of lupus nephritis.
Topics: Adult; Brain Diseases; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Immunosuppressive | 1992 |
[Further observations on the cortisonic and aldosterone potentiation of the action of angiotensin in man].
Topics: Adult; Aldosterone; Angiotensin II; Betamethasone; Blood Pressure; Cardiovascular Diseases; Drug Syn | 1967 |
[Experimental results on the diabetogenic effect of fluprednisolone in the corticoid-glucose-tolerance-test].
Topics: Adult; Aged; Blood Glucose; Cardiovascular Diseases; Dexamethasone; Diabetes Mellitus; Fluprednisolo | 1969 |
[Steroids and nephrectomy cardiopathy].
Topics: Animals; Calcinosis; Cardiovascular Diseases; Desoxycorticosterone; Estradiol; Ethylestrenol; Heart | 1970 |
[Electrocardiographic studies in patients with infectious hepatitis, cardio-vascular diseases and symptoms of heart and coronary insufficiency during treatment with corticosteroids (prednisolone)].
Topics: Cardiovascular Diseases; Electrocardiography; Female; Heart; Hepatitis A; Humans; Middle Aged; Predn | 1968 |